Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease.
Sign Up to like & getrecommendations! Published in 2017 at "Inflammatory bowel diseases"
DOI: 10.1097/mib.0000000000001232
Abstract: To the Editors: Despite the introduction of new biological therapies, many patients with inflammatory bowel disease remain refractory to available treatments.1 Thus, assessing whether specific biological agents can be safely used in combination is a… read more here.
Keywords: vulvo perianal; combination; disease; perianal disease ... See more keywords